← Back to Search

Suicide Prevention Therapies for University Students (CAMPUS Trial)

N/A
Recruiting
Led By Scott Compton, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 to 25 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up to 6 month follow-up
Awards & highlights

CAMPUS Trial Summary

This trialwill investigate the effectiveness of 4 ATSs to treat suicidal college students at CCCs. 700 participants ages 18-25 will receive either CAMS or TAU in Stage 1 and then be re-randomized to either CAMS or DBT in Stage 2.

Who is the study for?
This trial is for college students aged 18-25 experiencing moderate to severe suicidal thoughts, who are enrolled at the university and agree to video recording of therapy sessions. It's not for those with imminent risk, severe psychosis, or unable to stay in school.Check my eligibility
What is being tested?
The study tests four adaptive treatment strategies (ATSs) for suicidal ideation among students using a two-stage approach: initial treatment with CAMS or TAU, followed by re-randomization into higher intensity treatments like comprehensive DBT if needed.See study design
What are the potential side effects?
Since this trial involves psychological therapies rather than medications, side effects may include emotional discomfort during discussions about suicide and related issues but typically do not involve physical side effects.

CAMPUS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 25 years old.

CAMPUS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~to 6 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and to 6 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Non-Suicidal Self Injury - 6 month follow-up
Non-Suicidal Self Injury - Stage 1
Non-Suicidal Self Injury - Stage 2
+6 more

CAMPUS Trial Design

6Treatment groups
Experimental Treatment
Group I: 6Experimental Treatment2 Interventions
Subject assigned to TAU for Phase 1. Subject is a Phase 1 TAU Insufficient Responder, then assigned to Phase 2 DBT.
Group II: 5Experimental Treatment2 Interventions
Subject assigned to TAU for Phase 1. Subject is a Phase 1 TAU Insufficient Responder, then assigned to Phase 2 CAMS.
Group III: 4Experimental Treatment2 Interventions
Subject assigned to TAU for Phase 1. Subject is a Phase 1 TAU Responder, thus placed into ongoing Maintenance/Monitoring.
Group IV: 3Experimental Treatment2 Interventions
Subject assigned to CAMS for Phase 1. Subject is a Phase 1 CAMS Insufficient Responder, then assigned to Phase 2 DBT.
Group V: 2Experimental Treatment2 Interventions
Subject assigned to CAMS for Phase 1. Subject is a Phase 1 CAMS Insufficient Responder, then assigned to Phase 2 CAMS.
Group VI: 1Experimental Treatment2 Interventions
Subject assigned to CAMS for Phase 1. Subject is a Phase 1 CAMS Responder, thus placed into ongoing Maintenance/Monitoring.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Treatment As Usual (TAU)
2022
Completed Phase 3
~2540

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,360 Previous Clinical Trials
3,419,630 Total Patients Enrolled
12 Trials studying Suicide
2,828 Patients Enrolled for Suicide
National Institute of Mental Health (NIMH)NIH
2,784 Previous Clinical Trials
2,688,577 Total Patients Enrolled
112 Trials studying Suicide
1,156,119 Patients Enrolled for Suicide
Scott Compton, PhDPrincipal InvestigatorDuke University
1 Previous Clinical Trials
84 Total Patients Enrolled
1 Trials studying Suicide
84 Patients Enrolled for Suicide

Media Library

Collaborative Assessment and Management of Suicidality (CAMS) - Phase 1 Clinical Trial Eligibility Overview. Trial Name: NCT04707066 — N/A
Suicide Research Study Groups: 4, 5, 6, 1, 2, 3
Suicide Clinical Trial 2023: Collaborative Assessment and Management of Suicidality (CAMS) - Phase 1 Highlights & Side Effects. Trial Name: NCT04707066 — N/A
Collaborative Assessment and Management of Suicidality (CAMS) - Phase 1 2023 Treatment Timeline for Medical Study. Trial Name: NCT04707066 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study open to senior citizens for participation?

"This clinical trial is open to participants aged 18 and above, but not exceeding 25 years old."

Answered by AI

Are there any vacancies left for prospective participants of this research?

"As indicated on Clinicaltrials.gov, this research is currently recruiting participants; the trial was initially posted and last edited on October 25th 2022."

Answered by AI

Am I eligible to take part in this research project?

"Patients within the age bracket of 18 to 25 who have attempted suicide are eligible for this study. A maximum of 700 individuals will be accepted into the trial."

Answered by AI

Are there a plethora of sites in this locale where the examination is taking place?

"Rutgers University in New Brunswick, Duke University in Durham and the Univeristy of Nevada - Reno are amongst the 4 medical sites actively recruiting for this trial. There is also with additional locations offering enrollment opportunities."

Answered by AI

What is the magnitude of enrollment for this medical experiment?

"Yes, according to clinicaltrials.gov this medical study is actively seeking participants. It was initially posted on October 25th 2022 and the information has since been updated. The trial plans to enlist 700 patients from 4 different locations across the country."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Comprehensive Adaptive Multisite Prevention of University Student Suicide
2022. "Comprehensive Adaptive Multisite Prevention of University Student Suicide". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04707066.
~266 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top